151 related articles for article (PubMed ID: 7701036)
1. Correlations of phosphomonoesters measured by phosphorus-31 magnetic resonance spectroscopy in the frontal lobes and negative symptoms in schizophrenia.
Shioiri T; Kato T; Inubushi T; Murashita J; Takahashi S
Psychiatry Res; 1994 Dec; 55(4):223-35. PubMed ID: 7701036
[TBL] [Abstract][Full Text] [Related]
2. Multiple regression analysis of relationship between frontal lobe phosphorus metabolism and clinical symptoms in patients with schizophrenia.
Shioiri T; Someya T; Murashita J; Kato T; Hamakawa H; Fujii K; Inubushi T
Psychiatry Res; 1997 Dec; 76(2-3):113-22. PubMed ID: 9522403
[TBL] [Abstract][Full Text] [Related]
3. Lateralized abnormality of high-energy phosphate and bilateral reduction of phosphomonoester measured by phosphorus-31 magnetic resonance spectroscopy of the frontal lobes in schizophrenia.
Kato T; Shioiri T; Murashita J; Hamakawa H; Inubushi T; Takahashi S
Psychiatry Res; 1995 Sep; 61(3):151-60. PubMed ID: 8545499
[TBL] [Abstract][Full Text] [Related]
4. 31P-spectroscopy of frontal lobe in schizophrenia: alterations in phospholipid and high-energy phosphate metabolism.
Yacubian J; de Castro CC; Ometto M; Barbosa E; de Camargo CP; Tavares H; Cerri GG; Gattaz WF
Schizophr Res; 2002 Dec; 58(2-3):117-22. PubMed ID: 12409151
[TBL] [Abstract][Full Text] [Related]
5. Cortical-striatal-thalamic circuits and brain glucose metabolic activity in 70 unmedicated male schizophrenic patients.
Siegel BV; Buchsbaum MS; Bunney WE; Gottschalk LA; Haier RJ; Lohr JB; Lottenberg S; Najafi A; Nuechterlein KH; Potkin SG
Am J Psychiatry; 1993 Sep; 150(9):1325-36. PubMed ID: 8352343
[TBL] [Abstract][Full Text] [Related]
6. Basal ganglia phosphorous metabolism in chronic schizophrenia.
Deicken RF; Calabrese G; Merrin EL; Fein G; Weiner MW
Am J Psychiatry; 1995 Jan; 152(1):126-9. PubMed ID: 7802103
[TBL] [Abstract][Full Text] [Related]
7. Asymmetry of temporal lobe phosphorous metabolism in schizophrenia: a 31phosphorous magnetic resonance spectroscopic imaging study.
Deicken RF; Calabrese G; Merrin EL; Vinogradov S; Fein G; Weiner MW
Biol Psychiatry; 1995 Sep; 38(5):279-86. PubMed ID: 7495921
[TBL] [Abstract][Full Text] [Related]
8. Changes in levels of phosphorus metabolites in temporal lobes of drug-naive schizophrenic patients.
Fukuzako H; Fukuzako T; Hashiguchi T; Kodama S; Takigawa M; Fujimoto T
Am J Psychiatry; 1999 Aug; 156(8):1205-8. PubMed ID: 10450261
[TBL] [Abstract][Full Text] [Related]
9. Abnormal frontal lobe phosphorous metabolism in bipolar disorder.
Deicken RF; Fein G; Weiner MW
Am J Psychiatry; 1995 Jun; 152(6):915-8. PubMed ID: 7755123
[TBL] [Abstract][Full Text] [Related]
10. 31phosphorus magnetic resonance spectroscopy of the frontal and parietal lobes in chronic schizophrenia.
Deicken RF; Calabrese G; Merrin EL; Meyerhoff DJ; Dillon WP; Weiner MW; Fein G
Biol Psychiatry; 1994 Oct; 36(8):503-10. PubMed ID: 7827212
[TBL] [Abstract][Full Text] [Related]
11. Detection of metabolites in the white matter of frontal lobes and hippocampus with proton in first-episode treatment-naïve schizophrenia patients.
He ZL; Deng W; Li ML; Chen ZF; Collier DA; Ma X; Li T
Early Interv Psychiatry; 2012 May; 6(2):166-75. PubMed ID: 21951785
[TBL] [Abstract][Full Text] [Related]
12. Decreased energy demanding processes in the frontal lobes of schizophrenics due to neuroleptics? A 31P-magneto-resonance spectroscopic study.
Volz HP; Rzanny R; Rössger G; Hübner G; Kreitschmann-Andermahr I; Kaiser WA; Sauer H
Psychiatry Res; 1997 Dec; 76(2-3):123-9. PubMed ID: 9522404
[TBL] [Abstract][Full Text] [Related]
13. Grey and white matter differences in brain energy metabolism in first episode schizophrenia: 31P-MRS chemical shift imaging at 4 Tesla.
Jensen JE; Miller J; Williamson PC; Neufeld RW; Menon RS; Malla A; Manchanda R; Schaefer B; Densmore M; Drost DJ
Psychiatry Res; 2006 Mar; 146(2):127-35. PubMed ID: 16497488
[TBL] [Abstract][Full Text] [Related]
14. Altered phospholipid metabolism in schizophrenia: a phosphorus 31 nuclear magnetic resonance spectroscopy study.
Weber-Fahr W; Englisch S; Esser A; Tunc-Skarka N; Meyer-Lindenberg A; Ende G; Zink M
Psychiatry Res; 2013 Dec; 214(3):365-73. PubMed ID: 24045051
[TBL] [Abstract][Full Text] [Related]
15. Neurochemical investigation of the schizophrenic brain by in vivo phosphorus magnetic resonance spectroscopy.
Fukuzako H
World J Biol Psychiatry; 2001 Apr; 2(2):70-82. PubMed ID: 12587188
[TBL] [Abstract][Full Text] [Related]
16. Phosphorus magnetic resonance spectroscopy in schizophrenia: correlation between membrane phospholipid metabolism in the temporal lobe and positive symptoms.
Fukuzako H; Fukuzako T; Takeuchi K; Ohbo Y; Ueyama K; Takigawa M; Fujimoto T
Prog Neuropsychopharmacol Biol Psychiatry; 1996 May; 20(4):629-40. PubMed ID: 8843487
[TBL] [Abstract][Full Text] [Related]
17. [Hypofrontality and negative symptoms in schizophrenia: synthesis of anatomic and neuropsychological knowledge and ecological perspectives].
Semkovska M; Bédard MA; Stip E
Encephale; 2001; 27(5):405-15. PubMed ID: 11760690
[TBL] [Abstract][Full Text] [Related]
18. [Magnetic resonance spectroscopy in schizophrenia].
Delamillieure P; Constans JM; Fernandez J; Dollfus S
Encephale; 2000; 26(1):21-31. PubMed ID: 10875059
[TBL] [Abstract][Full Text] [Related]
19. 31Phosphorus magnetic resonance spectroscopy of the temporal lobes in schizophrenia.
Calabrese G; Deicken RF; Fein G; Merrin EL; Schoenfeld F; Weiner MW
Biol Psychiatry; 1992 Jul; 32(1):26-32. PubMed ID: 1391294
[TBL] [Abstract][Full Text] [Related]
20. Frontal lobe membrane phospholipid metabolism and ventricle to brain ratio in schizophrenia: preliminary 31P-MRS and CT studies.
Shioiri T; Hamakawa H; Kato T; Fujii K; Murashita J; Inubushi T; Someya T
Eur Arch Psychiatry Clin Neurosci; 2000; 250(4):169-74. PubMed ID: 11009069
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
